We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Although Langerhans cell histiocytosis (LCH) was first described a century ago, the aetiology is still not understood. Recent studies on the role of cytokines, chemokines, immunological dysfunction, cell surface antigen expression, clonality and cell-cycle regulation have provided new insights into the pathogenesis of LCH. Much of the data from these studies points to the Langerhans cell (LC) being intrinsically abnormal in LCH. Studies have shown that there is a proliferation of clonal LCs in the lesions of LCH. Furthermore, these LCH cells not only have differences in cytoplasmic and surface markers compared to the normal LC but also show abnormalities in cytokine production and antigen presentation. The recent progress in LCH research has provoked much discussion on whether LCH is a reactive disease resulting from environmental triggers, or a neoplastic process (Arceci et al., 2002; Egeler et al., 2004; Nezelof and Basset, 2004). Unfortunately, there is as yet no clear answer.
Continuing progress in the field of dendritic cell (DC) biology has allowed us to gain an increased understanding of the phenotype and function of LCH cells and their interaction with their microenvironment and hence the pathophysiology of this disease. Conversely, LCH, as an in vivo example of a DC abnormality, may serve as a ‘lesson’ to DC biologists (Laman et al., 2003). This chapter summarises some of the most recent studies investigating the immunological basis of LCH.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.